Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial

This publication has 16 references indexed in Scilit:

• Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
  Practical Radiation Oncology, 2020
• Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR).
  Journal of Clinical Oncology, 2018
• Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO‐IMPACT study
  Cancer, 2017
• Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
  Journal of Clinical Oncology, 2016
• Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men
  European Urology, 2016
• Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
  JNCI: Journal of the National Cancer Institute, 2009
• Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
  JNCI: Journal of the National Cancer Institute, 2008
• REporting recommendations for tumour MARKer prognostic studies (REMARK)
  British Journal of Cancer, 2005
• A Proportional Hazards Model for the Subdistribution of a Competing Risk
  Journal of the American Statistical Association, 1999
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
  The Annals of Statistics, 1988